Sintx Technologies (SINT) Share-based Compensation Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 2,844.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,844.44% |
| Dec 31, 2025 | 9,200.00% |
| Sep 30, 2025 | 5,360.00% |
| Jun 30, 2025 | 1,066.67% |
| Mar 31, 2025 | -64.00% |
| Dec 31, 2024 | -89.55% |
| Sep 30, 2024 | -85.07% |
| Jun 30, 2024 | -78.87% |
| Mar 31, 2024 | -41.86% |
| Dec 31, 2023 | -24.72% |
| Sep 30, 2023 | -25.56% |
| Jun 30, 2023 | -19.32% |
| Mar 31, 2023 | -15.69% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -13.46% |
| Jun 30, 2022 | 10.00% |
| Mar 31, 2022 | 183.33% |
| Dec 31, 2021 | 456.25% |
| Sep 30, 2019 | -80.00% |
| Dec 31, 2018 | -95.65% |
| Sep 30, 2018 | -90.74% |
| Jun 30, 2018 | -83.05% |
| Mar 31, 2018 | -60.00% |
| Dec 31, 2017 | -25.81% |
| Sep 30, 2017 | -3.57% |
| Jun 30, 2017 | 3.51% |
| Mar 31, 2017 | -31.82% |
| Dec 31, 2016 | -69.90% |
| Sep 30, 2016 | -41.67% |
| Jun 30, 2016 | -36.67% |
| Mar 31, 2016 | -86.67% |
| Dec 31, 2015 | 37.33% |
| Sep 30, 2015 | -95.26% |
| Jun 30, 2015 | -98.79% |
| Mar 31, 2015 | -52.99% |
| Dec 31, 2014 | -13.79% |
| Sep 30, 2014 | 5,234.21% |
| Jun 30, 2014 | 2,398.32% |
| Mar 31, 2014 | 2,952.17% |